chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vomiting; diarrhea; Initial information was received on 30-Nov-2020 regarding an unsolicited valid non-serious case from patient's child via social media.  The case was cross-referenced to 2020SA345890 (case for mother).  This case involves an adult male patient of unknown age who had vomiting and diarrhea (diarrhoea), after being vaccinated with INFLUENZA VACCINE.  Medical history, past medical treatment, vaccination, family history and concomitant medications were not provided.  On an unknown date, the patient received an INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date were not reported] at an unknown dose, via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, patient was in bed suffering from vomiting and diarrhea (diarrhoea) for 3 days (unknown latency), following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  Corrective treatment and outcome were unknown at the time of reporting.  There will be no information available on the batch number for this case.
Nausea, vomitting - Blood clot on kidney.  No hx of clotting issues prior.
A nurse practitioner reported that a 57 year old female received an injection of flu shield on 12/06/2001 and immediately experienced a feeling of heaviness in her arm and shoulder. Later that day, her symptoms resolved. At the date of the report no further info was available. This is 1 of 2 pts from this facility who experienced an adverse event following receipt of flu shield vaccine.(2001-2002 formula)lot 4018041 FOLLOW-UP information received from the reporter on 02/02/2002, provided physician information and stated that the patient had no residual effect. (See HQ9313510DEC2001)
This spontaneous report was received from a physician referring to an unspecified number of patients of unknown ages and genders. The patients' concurrent conditions and medical histories were not reported. On unknown dates the patients were vaccinated with improperly stored doses of ROTATEQ (Lot # reported as L008459, expiration date 18-DEC-2016) dose, route and anatomical location were unknown. There was no concomitant medication reported. The vaccines experienced the following temperature excursions on unknown dates: 29 F for 21 days. Reportedly, there had been no previous temperature excursions and the aforementioned ones were not identified due to a data logger. It was reported that ROTATEQ was supported, the product was suitable for use. This is one of several reports received from the same source. Additional information has been requested.
Narrative:  Patient completed COVID series in March 2021. Hospitalized with COVID-19 8/12/21 after presenting with shortness of breath, weakness, and decreased ap/petite, as well as Afib with RVR. Treated with remdesivir (8/12-17) and dexamethasone Discharged to nursing home 8/27/21
Urticarial rash. Onset 8/21/07 am. Seen in office on 8/21/07. Treated with Benadryl 12.5 mg/ 5 ml. 0.25 ml po q 8 hrs.
Patient called and reported a rash on her neck that appeared 3 days after her 2nd shingrix dose (12/17/2020) and it has not yet resolved. she asked what I recommended to help with the rash. she's tried tea tree shampoo and I suggested she takes an antihistamine and hydrocortisone otc. suggested patient goes to urgent care if does not resolve in a few days after starting otc meds.
Emblematic stroke in vision and language centers of brain causing blurred vision and aura as well as facial droop and slurred speach.
This spontaneous report was received from another health professional regarding a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) (lot # K021935 expiry date 10-NOV-2016) (dose and route unknown). No adverse events were reported. Follow up information has been received from the reporting C.M.A. during a phone call on 04-NOV-2015. The medical assistant reported that she would have to research the request made for patient identifiers, lot numbers, expiration dates and dates of vaccination. This is one of the two reports received from the same reporter. Follow up information has been received from the C.M.A. via other source on 24-NOV-2015 concerning a patient of unknown age and gender. The reporter stated that the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) on 09-FEB-2015. This was one of several reports received from the same reporter. Additional information has been requested. Reporter information, patient demographics therapy start date, event onset date and narrative were updated.
pt recv vax 1120AM c/o dry heaves, eye swelling & gagging;recv epi & p/15min began c/o feet itching;12noon given DPH sx began resolving;
7/9 Pt stated her arm was a little sore the day following injection. Her arm continued to get more red & swollen & hot to touch & painful.
In addition to CDC expected symptoms (swelling of the face, tiredness, headache, muscle pain, chills, diarrhea) the patients experienced chest pain, loss of taste, sore throat, runny nose, face muscle spam and unable to stand and dizziness.
Pt experienced malaise 9 days, post vax. She experienced severe headache and severe fatigue and myalgia 10 days, post vax. About 12 days, post vax, she had a rash on her face, chest and arms  and ended about 15 days, post vax. She treated the pain with Aleve. Pt missed work and school.
not feeling good; diarrhea; This is a spontaneous report from a contactable consumer. The reporter is the patient. An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 09Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "not feeling good"; DIARRHOEA (non-serious) with onset 29Mar2021, outcome "unknown", described as "diarrhea". Clinical course: the patient received a vaccine on 09Mar2021. She had to go back on the 30th. She did not as she was not feeling good. The patient asked how long she has to get 2nd one. She had a bad bout with diarrhea on the 29. The patient also asked if it is ok to get vaccinated when she don't feel good.   No follow-up attempts are possible. No further information is expected.
mom reported fever 102.6 on 12JAN to 104 on 13JAN while on APAP; to ER on 13JAN placed on children's Motrin; condition improved by 15JAN94;
nausea, weakness, & vertigo w/all capusles; therapy initiated was to cont to take the capsules; had injectable about 10 yrs ago & had sx; 1st capsule sx lasted 7 hrs; 2nd capsule sx lasted 4 hrs; 3rd capsule sx 2 hrs; 4th cap dizziness;
Around September 1, I noticed new hearing loss in my left ear. I thought my hearing aid battery had died (the amount of loss was very similar to having one hearing aid dead/out), but that was not the case. My ear also felt/feels partially clogged, but with no pressure, pain or any discomfort. There has been no noticeable change since onset.
Arm extremely painful and swollen. Pain acute enough to wake me from sleep, acetaminophen does not help. Got progressively worse as the afternoon progressed, peaked overnight, and is slowly getting better.
Moments after receiving Hep A #2 dizziness, nausea, stomachache. Very drowsy. Pt lying down, vitals every 5 minutes, stable. Tongue tingling a little after 1 hour which improved over next 20-30 minutes. 25 mg Benadryl given. Pt felt better. Stomachache and nausea gone, dizziness improved.
the hair was completely white grey and now is starting to have black hair; This spontaneous case was reported by a consumer and describes the occurrence of HAIR COLOUR CHANGES (the hair was completely white grey and now is starting to have black hair) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAIR COLOUR CHANGES (the hair was completely white grey and now is starting to have black hair). At the time of the report, HAIR COLOUR CHANGES (the hair was completely white grey and now is starting to have black hair) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Day after and for a few days ,strong pain in arm.  On January 11th , 9 days after the injection, I have  pink at the injection site and a rash about 2 inches long below the injection site.  No fever  but itching. The rash just appeared yesterday evening.
65-year-old female past medical history anxiety, depression, DM, hypertension presents to ED complaint of generalized weakness and fatigue x3 to 4 weeks that has progressively worsened. Patient reports she got her second Covid vaccine on April 27 and soon after that her symptoms started. Patient also has noted nausea, decreased appetite, chills, diarrhea x2 weeks, frequent falls. Patient ports diarrhea is mucus-like and usually very small amount. Patient states the falls occur as she feels her left lower extremity gives out on her when she is walking, she believes she has fallen every other day for the whole month of May. Patient has hit her head several times, unsure if she is experienced LOC after the falls. Patient also has noted left low back pain radiating to left lower extremity, left knee pain are result of the frequent falls
Started off with a headache and chills and then progressed a fever of 101.6, severe headache, muscle aches, mile shortness of breath, and dizziness.
Ganglions; Bone pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SYNOVIAL CYST (Ganglions), BONE PAIN (Bone pain) and PYREXIA (Fever) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004c21a and 046a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SYNOVIAL CYST (Ganglions), BONE PAIN (Bone pain) and PYREXIA (Fever). At the time of the report, SYNOVIAL CYST (Ganglions), BONE PAIN (Bone pain) and PYREXIA (Fever) outcome was unknown.            After second dose patient reported that some doctors said the cause was the vaccine and sent him to his house and his HCP told him not to receive booster dose. It was also reported that Patient went to the Hospital 3-4 times. Treatment medication stated using antibiotic dicloxacillin for the ganglions but patient mentioned nothing works and a lot of medication that didn't helped.  Concomitant medications stated a lot of medication without specifying any.     This case was linked to MOD-2021-407124 (Patient Link).
CC:  "Itchy red rash x 3 weeks"-started 1 week after smallpox, anthrax, and typhoid vaccination.  Patient received smallpox vaccine (Revaccinee), Anthrax #1, and Typhoid on 2/6/04.  No complaints on this date.  On 2/10/04, he developed mild flu-like symptoms with fever around 100 F.  Was evaluated and treated with Sudafed, throat lozenges, and anti-pyretics.  On 2/13/04, Service member noted flat red rash on bilateral arms.  Described it as "mildly itchy" and started taking Claritin QAM and Benadryl QPM.  Denies fever, headache, shortness of breath, chest pain, or abdominal pain.  Flu-like symptoms resolving.  Over the next few days, similar lesions increased on bilateral upper extremities, lower back, inner thigh, and around ankle and lower legs.  No oral lesions, interdigital lesions, or lesions on palms or soles.    He received anthrax #2 on 2/24/04.  He developed a knot in right deltoid area at site of vaccination and had persistent rash but otherwise felt fine.  On 3/4/04, he was referred to Vaccine Healthcare Center.  He reports that the rash appears to be getting better.  He continues to experience mild itching that is controlled on the Claritin QAM and Benadryl QPM.  He states that he feels fine and is eagerly awaiting his upcoming deployment on 3/7/04.  Of note, service member has been residing in a local hotel and reports that he has noted small black bugs in the sheets.  He does not recall being bitten by the bugs.  He also has been using different soaps, detergents, and shampoo while staying at the hotel.  Diagnosis: (ICD 782.1)Non-specific Skin Eruption that occurred after receipt of Smallpox, Anthrax, and Typhoid vaccination.  Unresolved but improving at this time.  The appearance is not compatible with the classic presentation of Non-viral Pustulosis or Erythema Multiforme.  Differential Diagnosis includes Benign Lesions resulting from SPV, Contact Dermatitis, or Arthropod Reaction.  Treatment:  Continue with antihistamine.  Kenalog 0.1% cream-apply TID x 1-2 weeks.    Consulted with Dermatology and they concurred that rash is consistent with arthropod reaction versus Pseudo-Erythema Multiforme.  Lesions started resolving on 3/6/04 and have continued improving.
Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been recieived froma  registered nurse concerning an elementary school-aged child who on 22-FEB-2001 was vaccinated with a dose of VARIVAX (Merck). On 03-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
On the following day after vaccination, Saturday April 24th, "I" began vomiting in the afternoon around 2pm and could not keep anything down. Thelast time "I" vomited was around midnight; Also during this time "I" had an excruciating headache. The headache continued throughout Sunday, April 25th; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 at 08:30 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 24Apr2021 at 14:00, on the following day after vaccination in the afternoon, the patient experienced vomiting and could not keep anything down. The last time he vomited was around midnight and also during that time he had an excruciating headache where it was continued throughout Sunday, April 25th. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting was recovered on an unknown date in Apr2021, while the clinical outcome of the event excruciating headache was recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Contracted COVID-19 in December following return trip from trip.  Returned December 7, 2022.  FIrst "apparent" symptoms December 9, 2022.  But PCR test on December 9th reflected negative results to COVID-19, and Flu. Spouse PCR test on Dcember 10-with results received December 12, 2022, diagnosed positve with COVID-19.        Symptoms included fatigue, muscle aches and pains, chest pressure, congestion, coughing.  I viewed the symptoms mild, similar to those I experienced following COVID vaccine doses.
I have severe allergies now because from the shot I almost died; shot made my allergies like ten times worse; I have severe allergies now because from the shot I almost died; shot made my allergies like ten times worse; I can't hear you my allergies are horrible today; Light-headed; Cough; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration at 1 O'clock on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included allergies from an unknown date. The patient reported I'm on five different pills, I don't have them right now I didn't take up from the pharmacy yet. The patient stated, "I had to go to emergency room last night and I had a reaction to the vaccine and I have severe allergies now because from the shot I almost died. I can't hear you my allergies are horrible today. I started now with a cough, I have severe allergies and this all I had to go to hospital. I'm still like light-headed and I'm coughing too much and I never done it until I got the COVID shot. The events started couple of days after the injection. The patient further stated, "I have severe allergies and they thought I have a blood clot in my lung and I still have nothing wrong with that, my lungs and heart are fine. It's this shot the shot made my allergies like ten times worse. Now I'm in like on five different pills now." The patient reported no treatment received for the events, only thing they did is they done a test in my lung and everything is fine, my heart is fine so I'm doing pretty good. The event Cough started on 02Jun2021; other events started on unspecified date. The patient was hospitalized for the severe allergies now because from the shot she almost died. The outcome of event Cough and Light-headed was not recovered, outcome of other events was unknown.  Information on the lot/batch number has been requested.
Extreme pain in entire left shoulder area. So much so that couldn't sleep for 2 nights. Very limited range of motion and use of left arm due to extreme pain all around shoulder. Felt like arm had been ripped from shoulder and left to hang. Dead arm. Not tender or sore to touch at injection site. Pain felt more internal.
On 1& 2 dose patient had silly cough that disappeared after couple hrs; between 1 & 2, had unusual asthma attack lasting couple days; This is a spontaneous report from a contactable consumer (patient herself). A 62-years-old female non-pregnant patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date was not reported), via an unspecified route, administered in Arm Left on 08Mar2021 at 16:45 (Age at vaccination 62-years-old) as dose 1, single for covid-19 immunization at hospital. Medical history included high blood pressure and borderline diabetic from an unknown date and unknown if ongoing. The patient had no known allergies. Concomitant medications included levothyroxine (LEVOTHYROXINE), losartan (LOSARTAN), metformin (METFORMIN) and atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported. On an unspecified Mar2021, the consumer stated that on 1 & 2 doses, she had silly cough that disappeared after couple hrs and between 1 & 2, had unusual asthma attack lasting couple days. The adverse event resulted in emergency room/department or urgent care. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received steroid inject, antibiotic, prednisone cough supp as treatment for the events. The second dose was schedule on 29Mar2021. The clinical outcome of the event on 1& 2 dose patient had silly cough that disappeared after couple hrs was resolved on an unspecified date in 2021 and between 1 & 2, had unusual asthma attack lasting couple days was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient admitted for labor.  Delivery of 37 week infant.  Patient reported cough on second day of admission.  Tested for COVID which resulted detected.  No hypoxia.
Patient alerted RN in observation room after feeling "a little hot and lightheaded". She continues to say that she didn't want to fall and pass out in the room so she asked for help.  Pt was asked to lay down on the cot, blood pressure was taken by this nurse and found pt to have bp of 90/52.  Patient says that she usually gets nervous and scared with all shots and labwork in the past and experiences the same symptoms when getting shots.
Chills, fever, in middle of the night x 2 nights, and lightheadedness 03/24/18 morning.
Seen at hospital urgent care/ER on 8/12/04 with right upper arm showing erythema of 15x18 cm and induration of 7x141 cm. Diagnosed with cellulitis and given IM Rocephin and oral Keflex. Seen at Pediatric Care North on 8/13/04 showing right upper arm redness of 11x11 cm and minimal induration. Prescribed Duric of oral abx.
Left leg became very swollen due to lymph node swelling; This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (Left leg became very swollen due to lymph node swelling) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced LYMPHADENOPATHY (Left leg became very swollen due to lymph node swelling). At the time of the report, LYMPHADENOPATHY (Left leg became very swollen due to lymph node swelling) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Ultrasound scan: showed the swelling was due to lymph node swelling (abnormal) showed the swelling was due to lymph node swelling.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment: The patient was taking aspirin for the swelling before the ultrasound in anticipation of a blood clot. She has also been taking Tylenol, Aleve, and using elevation and compression for her leg.
Patient was discharged @ 1224 and reported feeling itchy on her face and needing to clear her throat. Dr. @ bedside for exam patient denies chest pain, shortness of breath all vital WNL. Zyrtec 10mg given by mouth @ 1240pm pt tolerated well. Discharged @ 12:55pm in no distress.
Stabbing pain over the right first metatarsophalangeal joint.  Intermittent.  No relation to activity.  Progressed to nightly burning over the area, waking me up from sleep or preventing me from falling asleep.
pt was seen in ED and admitted to hospital with cough, increased confusion, decreased ability to walk; admitted to hosp with ARDS related to COVID virus; positive for COVID; given supplemental O2 and Decadron; after 4 days pt was dc'd to home; per death certificate, pt died at home with COVID 19 being cause of death
pt recvd vax & pt c/o that the area around inj became hot, swollen & itchy;